Search research articles
Contact Us
Filters
Showing results (161-170 of 186) with videos related to
Page
of 19
Sort By:
Journal for Immunotherapy of Cancer
|
August 4, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer
Paola Bonaventura, Audrey Page, Olivier Tabone, et al.
British Journal of Cancer
|
October 13, 2017
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
Carmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, et al.
Breast Cancer Research and Treatment
|
May 4, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
Brian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Cancers
|
January 21, 2022
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network
Clémence Romeo, Olivia Le Saux, Margaux Jacobs, et al.
Genes, Chromosomes & Cancer
|
January 26, 2022
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis
Nicolas Macagno, Daniel Pissaloux, Arnaud de la Fouchardière, et al.
Gynecologic Oncology
|
October 26, 2021
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR)
Olivier Trédan, Magali Provansal, Cyril Abdeddaim, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
July 29, 2017
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS<sup>G12D</sup>-driven Pancreatic Tumorigenesis
Nicolas Chuvin, David F Vincent, Roxane M Pommier, et al.
NPJ Breast Cancer
|
April 17, 2021
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
Thomas Grinda, Natacha Joyon, Amélie Lusque, et al.
Cancers
|
March 10, 2022
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial
Jean-David Fumet, Emilie Lardenois, Isabelle Ray-Coquard, et al.
Nature Communications
|
July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma
Olivia Le Saux, Maude Ardin, Justine Berthet, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 186) with videos related to
Sort By:
Page
of 19
Journal for Immunotherapy of Cancer
|
August 4, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer
Paola Bonaventura, Audrey Page, Olivier Tabone, et al.
British Journal of Cancer
|
October 13, 2017
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
Carmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, et al.
Breast Cancer Research and Treatment
|
May 4, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
Brian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Cancers
|
January 21, 2022
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network
Clémence Romeo, Olivia Le Saux, Margaux Jacobs, et al.
Genes, Chromosomes & Cancer
|
January 26, 2022
Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis
Nicolas Macagno, Daniel Pissaloux, Arnaud de la Fouchardière, et al.
Gynecologic Oncology
|
October 26, 2021
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR)
Olivier Trédan, Magali Provansal, Cyril Abdeddaim, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
July 29, 2017
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS<sup>G12D</sup>-driven Pancreatic Tumorigenesis
Nicolas Chuvin, David F Vincent, Roxane M Pommier, et al.
NPJ Breast Cancer
|
April 17, 2021
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
Thomas Grinda, Natacha Joyon, Amélie Lusque, et al.
Cancers
|
March 10, 2022
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial
Jean-David Fumet, Emilie Lardenois, Isabelle Ray-Coquard, et al.
Nature Communications
|
July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma
Olivia Le Saux, Maude Ardin, Justine Berthet, et al.
Page
of 19